Commissioning of a new sterility assurance manufacturing plant in Mentor, Ohio, expected to be operational by the end of calendar 2027.
Healthcare tuck-in acquisitions MEDglas and GI products are expected to add about $45 million of fiscal 2027 revenue.
AST multiyear X-ray capacity expansion is nearly complete, reducing capex intensity while adding sterilization capacity.
Fiscal 2026 guidance raise: constant-currency organic revenue growth lifted to 7%-8%, with EPS and free cash flow outlooks also increased.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for STERIS plc and 4,900+ companies.